Evidence map›Paper›PMID 28906529›Full record

ArticleCardiovascular journal of Africa

The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels.

Suna Aydin, Tuncay Kuloglu, Suleyman Aydin, Meltem Yardim, Davut Azboy, Zeki Temizturk, Ali Kemal Kalkan, Mehmet Nesimi Eren

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cardiovascular journal of Africa. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy.Oxidative medicine and cellular longevity · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Suna AydinDepartment of Cardiovascular Surgery, Elazig Education and Research Hospital, Health Science University, Elazig, Turkey; Department of Anatomy, School of Medicine, Firat University, Elazig, Turkey. Email: cerrah52@hotmail.com.
Tuncay KulogluDepartment of Histology and Embryology, School of Medicine, Firat University, Elazig, Turkey.
Suleyman AydinDepartment of Medical Biochemistry (Firat Hormones Research Group), School of Medicine, Firat University, Elazig, Turkey.
Meltem YardimDepartment of Medical Biochemistry (Firat Hormones Research Group), School of Medicine, Firat University, Elazig, Turkey.
Davut AzboyDepartment of Cardiovascular Surgery, Elazig Education and Research Hospital, Health Science University, Elazig, Turkey.
Zeki TemizturkDepartment of Cardiovascular Surgery, Elazig Education and Research Hospital, Health Science University, Elazig, Turkey.
Ali Kemal KalkanDepartment of Cardiology, Education and Research Hospital, Istanbul, Turkey.
Mehmet Nesimi ErenDepartment of Cardiovascular Surgery, School of Medicine, Dicle University, Diyarbakir, Turkey.
Dicle University · TRSağlık Bilimleri Üniversitesi · TRElazığ Eğitim ve Araştırma Hastanesi · TRFırat University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimInsufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia.

methodsThe study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess' assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson's trichrome staining, as well as levels of troponin and creatine kinase MB.

resultsIrisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents.

conclusionsIndividual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.

Indexed as

Adenosine TriphosphateAnimalsDisease Models, AnimalEnergy MetabolismFibronectinsIloprostKidneyLiverMaleMyocardial IschemiaMyocardial Reperfusion InjuryMyocardiumNitric OxideRats, Sprague-DawleySildenafil CitrateVasodilationAdenosine TriphosphateFibronectinsFNDC5 protein, ratIloprostNitric OxideSildenafil CitrateVasodilator Agents

Identifiers

PMID28906529
PMCPMC5885053
OpenAlexW2774009101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.